Global Diabetes Devices Market Set to Reach USD 70.6 Billion by 2035, Reports by Transparency Market Research

The global diabetes devices market is undergoing a transformative phase driven by technological innovation, growing health awareness, and the increasing prevalence of diabetes worldwide. According to the latest research, the global diabetes devices market was valued at US$ 32.4 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2035, reaching US$ 70.6 billion by 2035.

As the number of diabetic patients continues to rise globally, the demand for effective and user-friendly management devices, including continuous glucose monitoring (CGM) systems and insulin delivery solutions, has surged. These technological advances are reshaping diabetes care and empowering patients to monitor and manage their condition more efficiently than ever before.

Gain an understanding of key findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14

Market Overview: Diabetes is one of the fastest-growing chronic diseases globally, with over 400 million people currently affected, according to the World Health Organization. Lifestyle changes, rising obesity rates, and urbanization are key contributors to this alarming trend. Consequently, healthcare systems worldwide are turning to advanced diabetes management devices to help patients better control their condition and prevent complications.

The diabetes devices market is broadly segmented into glucose monitoring devices, insulin delivery devices, and diabetes management software, all of which play critical roles in helping patients and healthcare professionals achieve accurate, real-time monitoring and personalized treatment plans.
Moreover, the integration of digital health technologies, such as mobile applications, cloud-based analytics, and telehealth, is revolutionizing how diabetes is managed, allowing continuous patient-doctor connectivity and data-driven decision-making.

Key Drivers of Market Growth

1. Rising Global Prevalence of Diabetes

The escalating prevalence of diabetes remains the most significant factor driving the demand for diabetes devices. Sedentary lifestyles, poor dietary habits, and genetic predispositions are contributing to the increasing number of Type 1 and Type 2 diabetes cases. The International Diabetes Federation predicts that the global diabetic population will surpass 600 million by 2035, intensifying the need for reliable monitoring and insulin delivery systems.

2. Growing Demand for Home Healthcare and Self-Management

The shift toward home-based healthcare and self-management of chronic diseases has accelerated market growth. Patients are increasingly adopting portable, easy-to-use devices such as smart insulin pens, wireless glucose monitors, and app-connected pumps to manage their condition independently.
These devices enable patients to monitor glucose levels and insulin doses in real-time, offering greater convenience and improved quality of life while reducing hospital visits.

3. Technological Advancements and Connectivity

Continuous innovation is driving the market forward. The development of artificial pancreas systems, closed-loop insulin delivery, and cloud-connected glucose monitors has transformed diabetes management into a more automated and precise process. Integration with smartphones and wearables provides real-time alerts and comprehensive data analysis, facilitating personalized treatment and reducing the risk of complications.

Latest Market Trends

• Integration of AI and Data Analytics: Artificial Intelligence (AI) is being increasingly integrated into diabetes management platforms to analyze patterns in glucose data, predict fluctuations, and optimize insulin dosing.

• Telehealth and Remote Monitoring: The COVID-19 pandemic accelerated the adoption of telemedicine. Today, remote glucose monitoring and virtual consultations have become standard components of diabetes care.

• Miniaturized and Painless Monitoring Systems: Continuous glucose monitors are becoming smaller, more accurate, and painless, enhancing patient comfort and compliance.

• Smart Insulin Delivery Devices: Smart insulin pens and automated insulin pumps are designed to track doses and remind patients, improving medication adherence.

Key Players and Industry Leaders

The diabetes devices market features several prominent global players focusing on technological innovation, partnerships, and product diversification. Key market participants include:
• Medtronic plc
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• SOOIL Developments Co., Ltd
• F. Hoffmann-La Roche AG
• Ypsomed Holding AG
• Terumo Corporation
• MicroTech Medical, Inc.
• Jiangsu Delfu Co., Ltd.
• Medtrum Technologies Inc.
• Novo Nordisk A/S
• Sanofi
• Abbott Laboratories

These companies are actively developing and launching advanced diabetes management systems and expanding their global presence through strategic collaborations and product innovation.

Buy this Premium Research Report to stay informed with key insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=14<ype=S

Recent Developments

The industry is witnessing rapid innovation and expansion through product launches and regulatory approvals:

• February 2025: DexCom, Inc. introduced Dexcom ONE+, a customizable CGM system launched in Spain, Belgium, and Poland. The device includes a water-resistant sensor, transmitter, and smartphone app, providing users with seamless glucose tracking and improved flexibility in wear locations.

• January 2024: Medtronic plc received CE Mark approval for its MiniMed 780G system with Simplera Sync, offering a simplified two-step sensor insertion and a smaller design. The technology provides an enhanced user experience and supports real-time insulin adjustment.
These innovations are setting new standards for convenience, accuracy, and patient engagement in diabetes management.

Market New Opportunities and Challenges

Opportunities:

• Emerging Markets Growth: Rapid urbanization and increasing healthcare spending in Asia-Pacific, Latin America, and the Middle East present immense opportunities for device manufacturers.
• Integration with Wearable Technology: The merging of diabetes devices with smartwatches and fitness trackers is creating a more comprehensive ecosystem for health management.
• Rising Awareness and Preventive Healthcare: Public health campaigns promoting early diagnosis and glucose monitoring are expanding the potential customer base.

Challenges:
• High Device Costs: The affordability of advanced diabetes management devices remains a concern in low- and middle-income regions.
• Regulatory Hurdles: Stringent approval processes and varying international regulations can delay product launches.
• Data Security Concerns: With increased connectivity comes the challenge of ensuring secure data transmission and patient privacy.

Future Outlook

The global diabetes devices market is set to continue its strong growth trajectory through 2035. The combination of technological evolution, growing healthcare awareness, and increasing adoption of digital solutions will underpin market expansion.

Research into automated insulin delivery systems-often called the artificial pancreas-represents a major leap forward, promising reduced patient burden and improved glycemic control. Moreover, as governments and insurers promote preventive healthcare programs, the adoption of monitoring and insulin delivery devices will accelerate.

North America currently leads the global market due to its advanced healthcare infrastructure, high diabetes prevalence, and strong reimbursement support. Meanwhile, Asia-Pacific is projected to record the fastest growth, driven by a rapidly expanding diabetic population and increasing investments in healthcare technology.

Market Segmentation

By Product Type

• Glucose Monitoring Devices
o Self-Monitoring Devices (Blood Glucose Meters, Testing Strips, Lancets)
o Continuous Glucose Monitoring (Sensors, Transmitters, Receivers)
• Insulin Delivery Devices
o Insulin Syringes
o Insulin Pens
o Insulin Pumps
o Insulin Jet Injectors
• Diabetes Monitoring Software
• Artificial Pancreas Systems

By End User
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Homecare
• Others (Research Institutes)

By Region
• North America: United States, Canada
• Europe: Germany, U.K., France, Italy, Spain, Switzerland, Netherlands
• Asia-Pacific: China, India, Japan, South Korea, Australia, New Zealand
• Latin America: Brazil, Mexico, Argentina
• Middle East & Africa: GCC Countries, South Africa

Why Buy This Report?

This comprehensive report provides an in-depth assessment of the global diabetes devices market across multiple dimensions-technological, geographical, and strategic.

Key benefits include:
• Detailed Market Insights: Covering market size, growth rate, and forecast trends through 2035.

• Strategic Analysis: Identifies opportunities, challenges, and evolving market dynamics.

• Competitive Landscape: Comprehensive profiles of leading global and regional players.

• Segment-Level Data: Provides granular breakdown by product type, end-user, and region.

• Innovation Tracking: Highlights latest technological advancements and product launches.

• Investment Guidance: Helps investors and stakeholders make informed business decisions in an expanding global market.

With rising global health consciousness and continuous technological progress, the diabetes devices market stands at the forefront of medical innovation. From continuous glucose monitoring systems to artificial pancreas technology, the next decade promises to bring transformative change, redefining how millions of individuals worldwide manage diabetes.

Explore Latest Research Reports by Transparency Market Research:

Portable Medical Devices Market: https://www.transparencymarketresearch.com/portable-medical-devices-market.html

Surgical Drills Market: https://www.transparencymarketresearch.com/surgical-drills-market.html

Vision Impairment Devices Market: https://www.transparencymarketresearch.com/vision-impairment-devices-market.html

Medical Microbiology Testing Technology Market: https://www.transparencymarketresearch.com/microbiology-testing-technologies-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.